Literature DB >> 6821906

The myxomatous mitral valve and sudden death.

E Chesler, R A King, J E Edwards.   

Abstract

The clincopathologic features of 14 cases of sudden death attributable to dysrhythmias associated with the myxomatous mitral valve are described. The patients were 14-59 years old (mean 27 +/- 11 years). Eleven were female and three male. Of the seven ECGs available, none showed prolongation of the QT interval, but two showed repolarization abnormalities. The material was classified according to the degree of prolapse in the pathologic specimen. When obvious prolapse was found, the expected auscultatory findings had been documented. In three cases there was minimal prolapse, casting some doubt on the hypothesis that traction on the papillary muscles or diastolic dumping of the leaflets may be implicated in the pathogenesis of the dysrhythmias. In one of the cases with minimal prolapse there was a strong family history of sudden death. Endocardial friction lesions were present in 11 cases, including two of the three with minimal prolapse. In five cases there was a thrombotic lesion in the angle between the posterior leaflet and the left atrial wall containing fibrin and platelets. These abnormalities may be important in the pathogenesis of the ventricular dysrhythmias.

Entities:  

Mesh:

Year:  1983        PMID: 6821906     DOI: 10.1161/01.cir.67.3.632

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Physicians in opera--reflection of medical history and public perception.

Authors:  Stefan N Willich
Journal:  BMJ       Date:  2006-12-23

2.  Possible mechanism of late systolic mitral valve prolapse: systolic superior shift of leaflets secondary to annular dilatation that causes papillary muscle traction.

Authors:  Soshi Hei; Mai Iwataki; Jeong-Yoon Jang; Hiroshi Kuwaki; Keitaro Mahara; Shota Fukuda; Yun-Jeong Kim; Yosuke Nabeshima; Takeshi Onoue; Yasufumi Nagata; Shun Nishino; Nozomi Watanabe; Masaaki Takeuchi; Yosuke Nishimura; Jae-Kwan Song; Robert A Levine; Yutaka Otsuji
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-12-21       Impact factor: 4.733

3.  QT dispersion and ventricular arrhythmias in children with primary mitral valve prolapse.

Authors:  Ebru Yalın İmamoğlu; Ayşe Güler Eroğlu
Journal:  Turk Pediatri Ars       Date:  2016-09-01

4.  Surgical correction of mitral valve prolapse : a cure for recurrent ventricular tachycardia in Marfan syndrome?

Authors:  Rebecca S Beroukhim; John H Reed; Michael S Schaffer; Anji T Yetman
Journal:  Pediatr Cardiol       Date:  2006-09-30       Impact factor: 1.655

Review 5.  Mitral Valve Pathology.

Authors:  Gregory A Fishbein; Michael C Fishbein
Journal:  Curr Cardiol Rep       Date:  2019-05-23       Impact factor: 2.931

6.  A study of ECG pattern, cardiac structural abnormalities and familial tendency in patients with early repolarisation syndrome in South India.

Authors:  K G Madhu; Vijo George; T G Binu; R Ranjith; Subair Kunju; R Baiju; K S Mohanan; R Jayaram; V V Radhakrishnan
Journal:  Heart Asia       Date:  2014-12-08

Review 7.  Mitral leaflet billowing and prolapse. Implications for management.

Authors:  J B Barlow; W A Pocock
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

8.  Posture and Gender Differentially Affect Heart Rate Variability of Symptomatic Mitral Valve Prolapse and Normal Adults.

Authors:  Chien-Jung Chang; Ya-Chu Chen; Chih-Hsien Lee; Ing-Fang Yang; Ten-Fang Yang
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

9.  Minimally invasive surgery for valvular heart disease.

Authors:  Daniel G Cuadrado; Marzia Leacche; John G Byrne
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

Review 10.  Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis.

Authors:  Francesca N Delling; Ramachandran S Vasan
Journal:  Circulation       Date:  2014-05-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.